O Dr. Yildiz publicou extensivamente sobre tumores neuroendócrinos e casos oncológicos raros, com pesquisas apresentadas em revistas médicas internacionais.
O Prof. Wolfgang Köstler é especialista em terapias oncológicas direcionadas, com foco em malignidades mamárias e ginecológicas na Wiener Privatklinik.
Médica-chefe em um centro oncológico interdisciplinar certificado – a Dra. Viola Fox é especialista em tratamentos avançados para astrocitoma.
O Professor Associado Tahsin Ozatli é especialista em cancro da mama, do pulmão e gastrointestinal no Hospital Universitário Istinye Liv.
O Professor Keil é especializado em imagens avançadas e intervenções para astrocitoma no Centro Médico de Solingen.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
O Prof. Adjunto Nail Paksoy traz ampla experiência em oncologia médica, especializando-se em tratamentos de astrocitoma na Universidade Medipol de Istambul.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Definição dos primeiros critérios rigorosos para o diagnóstico de síndromes neurológicas paraneoplásicas – um avanço fundamental na neuro-oncologia. O Dr. Graus é investigador emérito no IDIBAPS.
Especializado em radioncologia na Universidade de Marmara – focado no direcionamento preciso de tumores para casos de astrocitoma.
O Professor Associado Dr. Emrah Eraslan é especialista em oncologia, com foco em astrocitoma no Hospital Privado Koru Ankara.
Diretor da Clínica de Hematologia, Oncologia e Imunologia Clínica do Hospital Universitário de Dusseldorf.